In an interview with PharmaShots, Ray Tabibiazar, M.D., Chief Executive Officer and Chairman, Board of Directors at SalioGen Therapeutics shares his views on the completion of $115M series B financing to advance gene coding platform for genetic diseases
Shots:
The company has completed $115M series B financing which was co-led by GordonMD global investments and EPIQ capital group. The financing will…
